CN108434262A - A kind of Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease - Google Patents
A kind of Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease Download PDFInfo
- Publication number
- CN108434262A CN108434262A CN201810702545.5A CN201810702545A CN108434262A CN 108434262 A CN108434262 A CN 108434262A CN 201810702545 A CN201810702545 A CN 201810702545A CN 108434262 A CN108434262 A CN 108434262A
- Authority
- CN
- China
- Prior art keywords
- parts
- gypsum
- myrrh
- treatment
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 78
- 201000010099 disease Diseases 0.000 title claims abstract description 43
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 43
- 241001478212 Riemerella anatipestifer Species 0.000 title claims abstract description 37
- 230000002265 prevention Effects 0.000 title claims abstract description 23
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 29
- 239000010440 gypsum Substances 0.000 claims abstract description 29
- 229940079593 drug Drugs 0.000 claims abstract description 23
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 22
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 22
- 240000008488 Thlaspi arvense Species 0.000 claims abstract description 21
- 235000008214 Thlaspi arvense Nutrition 0.000 claims abstract description 21
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 20
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 20
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 19
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 19
- 240000001851 Artemisia dracunculus Species 0.000 claims abstract description 19
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 19
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 19
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 19
- 241000157352 Uncaria Species 0.000 claims abstract description 19
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 19
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 19
- 244000272264 Saussurea lappa Species 0.000 claims abstract description 18
- 235000006784 Saussurea lappa Nutrition 0.000 claims abstract description 18
- 239000011148 porous material Substances 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 15
- 239000007788 liquid Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 240000000691 Houttuynia cordata Species 0.000 claims abstract 8
- 239000000126 substance Substances 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 4
- 244000126002 Ziziphus vulgaris Species 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 235000020995 raw meat Nutrition 0.000 claims 1
- 239000002023 wood Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 241000272525 Anas platyrhynchos Species 0.000 abstract description 19
- 235000021393 food security Nutrition 0.000 abstract description 5
- 241000607479 Yersinia pestis Species 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 19
- 206010062717 Increased upper airway secretion Diseases 0.000 description 13
- 208000026435 phlegm Diseases 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 13
- 241000758769 Houttuynia Species 0.000 description 12
- 210000002216 heart Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 230000002279 cholagogic effect Effects 0.000 description 9
- 230000036461 convulsion Effects 0.000 description 8
- 230000002936 tranquilizing effect Effects 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 239000003651 drinking water Substances 0.000 description 7
- 235000020188 drinking water Nutrition 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 6
- 230000001663 anti-spastic effect Effects 0.000 description 6
- 230000005906 menstruation Effects 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 4
- 210000000416 exudates and transudate Anatomy 0.000 description 4
- 235000021050 feed intake Nutrition 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 241000272522 Anas Species 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010040047 Sepsis Diseases 0.000 description 3
- 206010044565 Tremor Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000000994 depressogenic effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000565356 Fraxinus pennsylvanica Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 201000009906 Meningitis Diseases 0.000 description 2
- 240000009023 Myrrhis odorata Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000288049 Perdix perdix Species 0.000 description 2
- 206010071301 Perihepatitis Diseases 0.000 description 2
- 208000037581 Persistent Infection Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000007893 Salpingitis Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 201000010260 leiomyoma Diseases 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 206010030899 opisthotonus Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000008494 pericarditis Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- AYIRNRDRBQJXIF-NXEZZACHSA-N (-)-Florfenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)C=C1 AYIRNRDRBQJXIF-NXEZZACHSA-N 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 241000195622 Astasia Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 206010058556 Serositis Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 229960003760 florfenicol Drugs 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to the Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease, it is low effectively to solve prevention and treatment pest of duck good effect, treatment cost, prevents from remaining, it is ensured that the problem of food security medication, by weight meter：20 50 parts of cordate houttuynia, 10 40 parts of radix scutellariae, 10 35 parts of kuh-seng, 10 30 parts of field pennycress, 20 50 parts of oriental wormwood, 10 25 parts of uncaria, 15 40 parts of spina date seed, 10 20 parts of myrrh, 10 20 parts of earthworm, 10 35 parts of radix bupleuri, 20 65 parts of gypsum, 10 25 parts of root of Aucklandia lappa Decne, 10 20 parts of 10 30 parts of umbellate pore furgus and Radix Glycyrrhizae are made as material medicine, wherein, by myrrh, gypsum uses gauze wrapped respectively, then in the drug of remaining group component being put into container altogether, add water, it impregnates, intense fire is boiled, turn to be cooked by slow fire 30 minutes, add myrrh, gypsum boils 15 minutes, filtering, obtain liquid, liquid, which is concentrated into, is equivalent to 1g/mL containing crude drug amount.Abundant raw material of the present invention, preparation method is simple, preparation easy to produce, easy to use, and effect is good, at low cost, easily promotes and applies.
Description
Technical field
The present invention relates to veterinary drug, especially a kind of Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease.
Background technology
Riemerella anatipestifer disease is also known as duck infectious serositis, duck septicaemia, be one kind seriously threaten and influence duck,
The contact of the aquatic birds such as goose, acute or chronic infectious disease, 1-8 week old duck is sensitive, and the death rate reaches as high as 75%.To duck culturing industry
Bring prodigious economic loss.Its clinical symptoms is mainly based on pericarditis, air bag inflammation and perihepatitis.It is mainly shown as essence
God is depressed, and feeding is reduced, and astasia is all of a tremble, and neck is crooked, and starlike in seeing, two legs are stretched in opisthotonos posture.Cough
It coughs and gets rid of nose, open one's mouth to breathe, draw yellowish green loose stools, the gradual failure twitch that falls down to the ground is dead.The visible heart hydropericardium of dissect, envelope increase
Thickness, the external membrane of heart have fibrinous exudate, and air bag is muddy, thickens, and it is in canescence or sallow that surface, which is coated with fibroid exudate,
Color, liver enlargement, matter are crisp, are in khaki or brownish red, and envelope thickens, and opaque is in yellow-white, and spleen enlargement is mottled in red ash,
Gall-bladder is full.In the visible cellulosic meningitis of some chronic infections or meninx hyperemia, oedema or petechial hemorrhage and salpingitis
Deng.
Currently, in terms of the medical treatment measure of the disease, antibiotics and sulfa drugs are mainly applied, but in pest of duck
Mo Shi bacillus serotypes are more, are also easy to produce drug resistance, and laboratory result is found, different regions, different ducks its to the quick of drug
Larger difference existing for sense degree.Even if sensitivity of the sick duck of different batches to antibacterials in the same area, same field
There is also differents, therefore bring certain difficulty to the disease prevention and control.In addition, abuse, long-term or large dosage use antibiotic
Or anti-microbial type chemicals, endurance strain and medicament residue are often will produce, the food security of the mankind, research and development peace are seriously threatened
Entirely, efficiently, the treatment Riemerella anatipestifer disease of noresidue it is imperative.
Invention content
For the above situation, to overcome the defect of the prior art, the purpose of the present invention to be just to provide a kind of prevention and treatment
The Chinese medicine composition of Riemerella anatipestifer disease, it is low effectively to solve prevention and treatment pest of duck good effect, treatment cost, prevents residual
It stays, it is ensured that the problem of food security medication.
The technical solution that the present invention solves is a kind of Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease, root
According to the pathogenesis of Riemerella anatipestifer disease, the therapy rules for the treatment of of the disease are treated in conjunction with Chinese medicine, are intended using clearing heat and detoxicating, clear liver profit
Courage, tranquilizing the mind antispastic, promoting menstruation promoting the circulation of qi are eliminated phlegm for resuscitation for principle of reatment, and accordingly, the present invention is by following weight meter：Cordate houttuynia 20-
50 parts, 10-40 parts of radix scutellariae, 10-35 parts of kuh-seng, 10-30 parts of field pennycress, 20-50 parts of oriental wormwood, 10-25 parts of uncaria, spina date seed 15-
40 parts, 10-20 parts of myrrh, 10-20 parts of earthworm, 10-35 parts of radix bupleuri, 20-65 parts of gypsum, 10-25 parts of root of Aucklandia lappa Decne, 10-30 parts of umbellate pore furgus
It is made as material medicine for 10-20 parts with Radix Glycyrrhizae, wherein myrrh, gypsum are used into gauze wrapped respectively, then remaining group component
During drug is put into altogether in container, add the water of 10 times of material medicine weight, impregnates 1-2h, intense fire（Big fire）Liquid is boiled, text is turned
Fire（Small fire）It boils 30 minutes, adds myrrh, gypsum intense fire is fried boiling, then be cooked by slow fire 15 minutes, filter, obtain liquid, liquid concentration
To being equivalent to 1g/mL containing crude drug amount.
Abundant raw material of the present invention, preparation method is simple, preparation easy to produce, easy to use, and effect is good, at low cost, easily promotes
Using economic and social benefit is huge.
Specific implementation mode
The specific implementation mode of the present invention is described in detail with reference to embodiments.
The present invention in specific implementation, is provided by following embodiment.
Embodiment 1
The present invention in specific implementation, it is a kind of prevention and treatment Riemerella anatipestifer disease Chinese medicine composition, by following weight
Meter：30-40 parts of cordate houttuynia, 20-30 parts of radix scutellariae, 15-25 parts of kuh-seng, 15-25 parts of field pennycress, 30-40 parts of oriental wormwood, uncaria 15-
20 parts, 25-30 parts of spina date seed, 12-18 parts of myrrh, 12-18 parts of earthworm, 20-25 parts of radix bupleuri, 35-50 parts of gypsum, root of Aucklandia lappa Decne 15-20
12-18 parts of part, 15-25 parts of umbellate pore furgus and Radix Glycyrrhizae are made as material medicine, wherein myrrh, gypsum are used gauze wrapped respectively, then
During the drug of remaining group component is put into container altogether, add the water of 10 times of material medicine weight, impregnates 1-2h, intense fire（Big fire）It will
Liquid is boiled, and slow boiling is turned（Small fire）It boils 30 minutes, adds myrrh, gypsum intense fire is fried boiling, then be cooked by slow fire 15 minutes, filter, obtain
Liquid, liquid, which is concentrated into, is equivalent to 1g/mL containing crude drug amount.
Embodiment 2
The present invention in specific implementation, it is a kind of prevention and treatment Riemerella anatipestifer disease Chinese medicine composition, by following weight
Meter：35 parts of cordate houttuynia, 25 parts of radix scutellariae, 22.5 parts of kuh-seng, 20 parts of field pennycress, 35 parts of oriental wormwood, 17.5 parts of uncaria, spina date seed 27.5
15 parts of part, 15 parts of myrrh, 15 parts of earthworm, 22.5 parts of radix bupleuri, 42.5 parts of gypsum, 17.5 parts of root of Aucklandia lappa Decne, 20 parts of umbellate pore furgus and Radix Glycyrrhizae make former
Material drug is made, and the preparation method is the same as that of Example 1.
Embodiment 3
The present invention in specific implementation, it is a kind of prevention and treatment Riemerella anatipestifer disease Chinese medicine composition, by following weight
Meter：25 parts of cordate houttuynia, 15 parts of kuh-seng, 25 parts of field pennycress, 25 parts of oriental wormwood, 23 parts of uncaria, 18 parts of spina date seed, does not have 35 parts of radix scutellariae
18 parts of 18 parts of medicine, 13 parts of earthworm, 30 parts of radix bupleuri, 25 parts of gypsum, 22 parts of root of Aucklandia lappa Decne, 12 parts of umbellate pore furgus and Radix Glycyrrhizae are made as material medicine,
The preparation method is the same as that of Example 1.
Embodiment 4
The present invention in specific implementation, it is a kind of prevention and treatment Riemerella anatipestifer disease Chinese medicine composition, by following weight
Meter：45 parts of cordate houttuynia, 30 parts of kuh-seng, 15 parts of field pennycress, 42 parts of oriental wormwood, 12 parts of uncaria, 38 parts of spina date seed, does not have 15 parts of radix scutellariae
12 parts of 12 parts of medicine, 18 parts of earthworm, 15 parts of radix bupleuri, 60 parts of gypsum, 12 parts of root of Aucklandia lappa Decne, 28 parts of umbellate pore furgus and Radix Glycyrrhizae are made as material medicine,
The preparation method is the same as that of Example 1.
Embodiment 5
The present invention in the specific implementation, it is a kind of prevention and treatment Riemerella anatipestifer disease Chinese medicine composition, by following weight
Meter：30 parts of cordate houttuynia, 20 parts of kuh-seng, 25 parts of field pennycress, 40 parts of oriental wormwood, 20 parts of uncaria, 20 parts of spina date seed, does not have 40 parts of radix scutellariae
15 parts of 20 parts of medicine, 15 parts of earthworm, 20 parts of radix bupleuri, 45 parts of gypsum, 18 parts of root of Aucklandia lappa Decne, 15 parts of umbellate pore furgus and Radix Glycyrrhizae are made as material medicine,
The preparation method is the same as that of Example 1.
Embodiment 6
The present invention in the specific implementation, it is a kind of prevention and treatment Riemerella anatipestifer disease Chinese medicine composition, by following weight
Meter：50 parts of cordate houttuynia, 10 parts of kuh-seng, 15 parts of field pennycress, 50 parts of oriental wormwood, 10 parts of uncaria, 30 parts of spina date seed, does not have 20 parts of radix scutellariae
20 parts of 10 parts of medicine, 20 parts of earthworm, 25 parts of radix bupleuri, 40 parts of gypsum, 15 parts of root of Aucklandia lappa Decne, 30 parts of umbellate pore furgus and Radix Glycyrrhizae are made as material medicine,
The preparation method is the same as that of Example 1.
Embodiment 7
The present invention in the specific implementation, it is a kind of prevention and treatment Riemerella anatipestifer disease Chinese medicine composition, by following weight
Meter：40 parts of cordate houttuynia, 15 parts of kuh-seng, 20 parts of field pennycress, 30 parts of oriental wormwood, 25 parts of uncaria, 27 parts of spina date seed, does not have 30 parts of radix scutellariae
10 parts of 13 parts of medicine, 16 parts of earthworm, 30 parts of radix bupleuri, 25 parts of gypsum, 24 parts of root of Aucklandia lappa Decne, 15 parts of umbellate pore furgus and Radix Glycyrrhizae are made as material medicine,
The preparation method is the same as that of Example 1.
In actual production, granule, pill, pulvis or other agent for being suitable for using can be also made in the present invention as needed
Type, according to production scale, every part of weight can be 1g, 10g, 100g, 1000g etc., be determined with specific reference to practical expense.
In said medicine, wherein cordate houttuynia, radix scutellariae, kuh-seng, field pennycress, gypsum have clearing heat and detoxicating purging intense heat effect, yellow
A kind of reed mentioned in ancient books enters the heart, lung channel, has purte the white, the hot phlegm and relieving cough effect in Qinghua；Cordate houttuynia, field pennycress have effects that carbuncle that disappears dissipating bind cool blood, are
Control the key medicine of internal carbuncle；There is gypsum expelling pathogenic factors from muscles for clearing heat, relieving restlessness to quench the thirst effect.It is not moved back for high fever, vexed coma, lung heat asthma is anxious etc.
Disease.Oriental wormwood clearing heat and promoting diuresis；Removing jaundice has a cholagogic, liver protection, it is anti-inflammatory the effect of, uncaria, spina date seed and earthworm there is The flat liver of heat-clearing, nourishing the liver
Calming heart, dispelling wind and relieving convulsion, tranquilizing the mind effect；Myrrh, root of Aucklandia lappa Decne have promoting circulation of blood analgesic efficacy, Radix Glycyrrhizae purging intense heat heat-clearing, tonifying spleen moisten the lung and relieve the cough and
Detoxification and liver protection cholagogic.All medicines share plays clearing heat and detoxicating, clearing liver cholagogic, tranquilizing the mind antispastic, promoting menstruation promoting the circulation of qi, the work(eliminated phlegm for resuscitation altogether.Group
/ science combination, is supported mutually, all medicines share plays clearing heat and detoxicating, clearing liver cholagogic, tranquilizing the mind antispastic, promoting menstruation promoting the circulation of qi, slit phlegm altogether
The effect of having one's ideas straightened out effective for treating Riemerella anatipestifer disease, and through applying and testing on the spot, achieves extraordinary beneficial
Technique effect, related testing data are as follows：
One, the standard of case is selected
According to Riemerella anatipestifer disease clinical symptoms, in conjunction with traditional Chinese veterinary medicine theory, Riemerella anatipestifer disease category " warm disease, urgency
Infantile convulsion " scope, position of causing a disease is the heart, liver, lung, using heat symptom-complex and real example as core.Belong to and being invaded in cult poison, wind-heat affecting lung, inverse telepathy
Liver sends out as acute infantile convulsions, continues and is contained for phlegm phlogiston, and wind contains raw phlegm, and phlegm is contained raw frightened, so that meat corruption blood loses, is formed at carbuncle suppuration or thermal burn
Blood network, body fluid deficiency, and toxin can not rule out, aggravated malicious blood, sepsis and cause.Clinical manifestation is that spirit is depressed, and feeding is reduced, and is stood
Vertical shakiness, is all of a tremble, and neck is crooked, and starlike in seeing, two legs are stretched in opisthotonos posture.Cough gets rid of nose, opens one's mouth to breathe, and draws
Yellowish green loose stools, the gradual failure twitch that falls down to the ground are dead.
By the alternatively standard of case of the sick duck with above-mentioned symptom.
Two, diagnostic criteria
All ducks with a clinical symptoms, and dissect is carried out to dead sick duck, it is seen that heart hydropericardium, envelope thicken, the heart
Outer membrane has fibrinous exudate, and air bag is muddy, thickens, and it is in canescence or lark, liver that surface, which is coated with fibroid exudate,
Dirty enlargement, matter are crisp, are in khaki or brownish red, and envelope thickens, and opaque is in yellow-white, and spleen enlargement is mottled in red ash, gall-bladder
It is full.In the visible cellulosic meningitis of some chronic infections or meninx hyperemia, oedema or petechial hemorrhage and salpingitis etc., i.e.,
It can make a definite diagnosis with Riemerella anatipestifer disease, Chinese medicine of the present invention is used in combination to be treated.
Three, therapeutic scheme
It is gavaged according to 1-2mL/kg weight, secondary daily, once in the morning and once at night, medication counts curative effect after 7 days.
Four, efficacy assessment standard
It cures：Symptom completely disappears, and the state of mind, feed intake, amount of drinking water restore normal, and the state of an illness is without phenomenon repeatedly.
Effectively：Symptom has clear improvement or improves, and the state of mind, feed intake, amount of drinking water return to normal.
In vain：Symptom is without improvement, or even has the trend of exacerbation, until dead.
Five, statistical procedures
1, drug test is carried out first：
（1）Animal packet：100 20 age in days health Huainan partridge ducks are randomly divided into 5 groups, every group 20, i.e., high, medium and low dosage
Treatment group infects control group, western medicine control group, isolated rearing 7d.
（2）Artificial challenge's model copy of Riemerella anatipestifer disease：Every sheldrake leg in each group is subcutaneously noted respectively
Penetrate inoculation riemerella anatipestifer bacterium solution（A concentration of 3.5 × 108cuf/mL）0.5mL, healthy control group duck inject sterile physiological
Brine 0.5mL/ is only.
（3）Start to be administered within 12 hours after experiment Huainan partridge duck inoculated bacteria, high, medium and low dosage treatment group is respectively with implementation
For herb liquid prepared by example 2 according to 2.0 mL/kg, 1.5mL/kg and 1.0mL/kg, western medicine control group can using Florfenicol
Molten powder（30mg/kg）, healthy control group drinking-water in do not add drug, each group experimental animal is continuously freely drunk, successive administration 7d,
Morbidity number, the death toll for counting each group duck, calculate cure rate and effective percentage.
（4）Statistical disposition：The death condition and therapeutic effect of each group duck are shown in Table 1
Sheldrake The dead quantity and treatment effectiveness evaluation after the treatment of 1 each group of table
By above-mentioned it should be apparent that the effective percentage of Chinese medicine group of the present invention is apparently higher than Western medicine group, show that Chinese medicine of the present invention is
The active drug of anti-treatment Riemerella anatipestifer disease.
2, it applies on the spot
On the basis of experiment ensures safety, 6000 sheldrakes through being raised to District, Xinyang Area, Henan Province farm, in 15 age in days parts
Sheldrake show feeding reduce or or it is useless exhausted, spirit is depressed, likes drinking water, is reluctant to walk about, and excrement is diluter, in yellow green or white
Color excrement, site morbidity duck occur turning round the nervous symptoms such as neck, its organ of dissect is mainly scorching in perihepatitis, pericarditis, air bag, will be sick
Duck tissue is separately cultured using laboratory bacterial, in conjunction with clinical symptoms and pathological change, is diagnosed as Riemerella anatipestifer disease（It passes
Metachromia scrositis）, treated using therapeutic scheme of the present invention and drug, morbidity sheldrake gavages administration, cluster according to 2mL/kg
According to 1mL/kg drinking water administrations, after being used in conjunction 5 days, 93% illness duck symptom completely disappears, the state of mind, feed intake, amount of drinking water
Restore normal, remaining duck continues medication treatment, there was only 158 death after 7 days, remaining state of mind, feed intake, amount of drinking water are equal
Return to normal, and do not occur Relapse rate phenomenon after 10 days, show it is curative for effect, it is reliable and stable.
Six, conclusion
According to Riemerella anatipestifer disease clinical symptoms, in conjunction with traditional Chinese veterinary medicine theory, Riemerella anatipestifer disease category is thought in research
" warm disease, acute infantile convulsions " scope, position of causing a disease is the heart, liver, lung, using heat symptom-complex and real example as core.Belong to and being invaded in cult poison, wind-heat is violated
Lung, inverse telepathy liver send out as acute infantile convulsions, continue and contained for phlegm phlogiston, and wind contains raw phlegm, phlegm contain it is raw frightened so that meat corruption blood loses, suppurate at carbuncle and
At or injury of blood collaterals by heat, body fluid deficiency, and toxin can not rule out, aggravated malicious blood, sepsis and cause.Control suitable clearing heat and detoxicating, clearing liver cholagogic,
Tranquilizing the mind antispastic, promoting menstruation promoting the circulation of qi, eliminate phlegm for resuscitation based on.Cordate houttuynia, radix scutellariae, kuh-seng, field pennycress, gypsum have heat-clearing in side in prescription
Removing toxic substances purging intense heat effect, wherein radix scutellariae enter the heart, lung channel, have purte the white, the hot phlegm and relieving cough effect in Qinghua；Cordate houttuynia, field pennycress have
Carbuncle that disappears dissipating bind cool blood effect, to control the key medicine of internal carbuncle；There is gypsum expelling pathogenic factors from muscles for clearing heat, relieving restlessness to quench the thirst effect.It is not moved back for high fever, the heart
Spend time and energy dusk, lung heat breathes heavily the diseases such as anxious.Oriental wormwood clearing heat and promoting diuresis；Removing jaundice has a cholagogic, liver protection, it is anti-inflammatory the effect of, uncaria, spina date seed and earthworm
With The flat liver of heat-clearing, nourishing the liver calming heart, dispelling wind and relieving convulsion, tranquilizing the mind effect；Myrrh, root of Aucklandia lappa Decne have promoting circulation of blood analgesic efficacy, Radix Glycyrrhizae purging intense heat clear
Heat, tonifying spleen moistens the lung and relieve the cough and detoxification and liver protection cholagogic.All medicines share plays clearing heat and detoxicating, clearing liver cholagogic, tranquilizing the mind antispastic, promoting menstruation row altogether
Gas, the work(eliminated phlegm for resuscitation.Reasonable recipe compatibility of the present invention, interaction, effective for treating Riemerella anatipestifer disease, this hair
Decoction can be not only made in bright Chinese medicine, may be made as other dosage forms for being suitable for taking.
Chinese medicine of the present invention is pure natural substance, has the function of clearing heat and detoxicating, clearing liver cholagogic, tranquilizing the mind antispastic, anti-inflammatory, and
And have no toxic side effect, almost noresidue is not likely to produce drug resistance, and the antibiotic residue for efficiently solving puzzlement animal husbandry development is asked
Topic, improves productivity, reduces environmental pollution, develops unpolluted animal husbandry, meets the food security demand of the people, enhances China
Livestock products are the innovations on Riemerella anatipestifer disease prevention and control drug in the competitiveness of international market.
The present invention has the following advantages compared with existing technology：
1. pure Chinese medicinal preparation has anti-multiple pathogenic microorganisms, have no drug resistance generation, searches out a kind of novel, effective solution
Certainly the problem of Riemerella anatipestifer disease；
2. antibiotic-free residue problem, reduces environmental pollution, effectively solves a series of food securities caused by chemicals and ask
Topic, meets the needs of present healthy living；
3. easy to use, curative effect is fast, and drug effect is apparent, and the drug has no adverse reaction；
4. preventing and cure rate being high, effective percentage is at least in 90% or more, even as high as 95% or more；
5. preparation method is simple, quality standard is controllable, is suitble to industrialized production, easy to spread, economic and social benefit is huge.
It is the specific implementation mode for illustrating the present invention it is noted that these are only the preferred embodiment of the present invention,
The protection domain being not intended to restrict the invention, for those skilled in the art, the present invention can have it is various change and
Variation.All within the spirits and principles of the present invention, made by any equivalent replacement, modification made by with the technology of the present invention side
Case technical solution of the same nature, all belongs to the scope of protection of the present invention.
Claims (8)
1. a kind of Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease, which is characterized in that by following weight meter：Fish
20-50 parts of raw meat grass, 10-40 parts of radix scutellariae, 10-35 parts of kuh-seng, 10-30 parts of field pennycress, 20-50 parts of oriental wormwood, 10-25 parts of uncaria, acid
15-40 parts of jujube kernel, 10-20 parts of myrrh, 10-20 parts of earthworm, 10-35 parts of radix bupleuri, 20-65 parts of gypsum, 10-25 parts of root of Aucklandia lappa Decne, umbellate pore furgus
10-30 parts are made with 10-20 parts of Radix Glycyrrhizae as material medicine, wherein myrrh, gypsum are used gauze wrapped respectively, then remaining
During the drug of group component is put into altogether in container, add the water of 10 times of material medicine weight, impregnate 1-2h, intense fire boils liquid, turns
It is cooked by slow fire 30 minutes, adds myrrh, gypsum intense fire is fried boiling, then be cooked by slow fire 15 minutes, filter, obtain liquid, liquid is concentrated into phase
When in 1g/mL containing crude drug amount.
2. the Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease according to claim 1, which is characterized in that by
Following weight meter：30-40 parts of cordate houttuynia, 20-30 parts of radix scutellariae, 15-25 parts of kuh-seng, 15-25 parts of field pennycress, 30-40 parts of oriental wormwood,
15-20 parts of uncaria, 25-30 parts of spina date seed, 12-18 parts of myrrh, 12-18 parts of earthworm, 20-25 parts of radix bupleuri, 35-50 parts of gypsum, wood
12-18 parts of 15-20 parts fragrant, 15-25 parts of umbellate pore furgus and Radix Glycyrrhizae are made as material medicine, and preparation method is the same as claim 1.
3. the Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease according to claim 1, which is characterized in that by
Following weight meter：35 parts of cordate houttuynia, 25 parts of radix scutellariae, 22.5 parts of kuh-seng, 20 parts of field pennycress, 35 parts of oriental wormwood, 17.5 parts of uncaria, acid
27.5 parts of jujube kernel, 15 parts of myrrh, 15 parts of earthworm, 22.5 parts of radix bupleuri, 42.5 parts of gypsum, 17.5 parts of root of Aucklandia lappa Decne, 20 parts of umbellate pore furgus and Radix Glycyrrhizae
15 parts are made as material medicine, and preparation method is the same as claim 1.
4. the Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease according to claim 1, which is characterized in that by
Following weight meter：25 parts of cordate houttuynia, 35 parts of radix scutellariae, 15 parts of kuh-seng, 25 parts of field pennycress, 25 parts of oriental wormwood, 23 parts of uncaria, spina date seed
18 parts of 18 parts, 18 parts of myrrh, 13 parts of earthworm, 30 parts of radix bupleuri, 25 parts of gypsum, 22 parts of root of Aucklandia lappa Decne, 12 parts of umbellate pore furgus and Radix Glycyrrhizae make bulk pharmaceutical chemicals
Object is made, and preparation method is the same as claim 1.
5. the Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease according to claim 1, which is characterized in that by
Following weight meter：45 parts of cordate houttuynia, 15 parts of radix scutellariae, 30 parts of kuh-seng, 15 parts of field pennycress, 42 parts of oriental wormwood, 12 parts of uncaria, spina date seed
12 parts of 38 parts, 12 parts of myrrh, 18 parts of earthworm, 15 parts of radix bupleuri, 60 parts of gypsum, 12 parts of root of Aucklandia lappa Decne, 28 parts of umbellate pore furgus and Radix Glycyrrhizae make bulk pharmaceutical chemicals
Object is made, and preparation method is the same as claim 1.
6. the Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease according to claim 1, which is characterized in that by
Following weight meter：30 parts of cordate houttuynia, 40 parts of radix scutellariae, 20 parts of kuh-seng, 25 parts of field pennycress, 40 parts of oriental wormwood, 20 parts of uncaria, spina date seed
15 parts of 20 parts, 20 parts of myrrh, 15 parts of earthworm, 20 parts of radix bupleuri, 45 parts of gypsum, 18 parts of root of Aucklandia lappa Decne, 15 parts of umbellate pore furgus and Radix Glycyrrhizae make bulk pharmaceutical chemicals
Object is made, and preparation method is the same as claim 1.
7. the Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease according to claim 1, which is characterized in that by
Following weight meter：50 parts of cordate houttuynia, 20 parts of radix scutellariae, 10 parts of kuh-seng, 15 parts of field pennycress, 50 parts of oriental wormwood, 10 parts of uncaria, spina date seed
20 parts of 30 parts, 10 parts of myrrh, 20 parts of earthworm, 25 parts of radix bupleuri, 40 parts of gypsum, 15 parts of root of Aucklandia lappa Decne, 30 parts of umbellate pore furgus and Radix Glycyrrhizae make bulk pharmaceutical chemicals
Object is made, and preparation method is the same as claim 1.
8. the Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease according to claim 1, which is characterized in that by
Following weight meter：40 parts of cordate houttuynia, 30 parts of radix scutellariae, 15 parts of kuh-seng, 20 parts of field pennycress, 30 parts of oriental wormwood, 25 parts of uncaria, spina date seed
10 parts of 27 parts, 13 parts of myrrh, 16 parts of earthworm, 30 parts of radix bupleuri, 25 parts of gypsum, 24 parts of root of Aucklandia lappa Decne, 15 parts of umbellate pore furgus and Radix Glycyrrhizae make bulk pharmaceutical chemicals
Object is made, and preparation method is the same as claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810702545.5A CN108434262A (en) | 2018-06-30 | 2018-06-30 | A kind of Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810702545.5A CN108434262A (en) | 2018-06-30 | 2018-06-30 | A kind of Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108434262A true CN108434262A (en) | 2018-08-24 |
Family
ID=63206946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810702545.5A Pending CN108434262A (en) | 2018-06-30 | 2018-06-30 | A kind of Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108434262A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006041933A2 (en) * | 2004-10-05 | 2006-04-20 | Diversa Corporation | Improved vaccines |
| CN102357148A (en) * | 2011-09-30 | 2012-02-22 | 青岛绿曼生物工程有限公司 | Pure Chinese herbal composition for treating Riemerella anatipestifer disease and preparation method thereof |
| CN105055586A (en) * | 2015-08-11 | 2015-11-18 | 河南科技大学 | Traditional Chinese medicine preparation used for preventing and treating cairna moschata infectious serositis |
| CN107715005A (en) * | 2017-11-10 | 2018-02-23 | 广西吉朋投资有限公司 | Prevent and treat Chinese medicine of duck infectious serositis and preparation method thereof |
-
2018
- 2018-06-30 CN CN201810702545.5A patent/CN108434262A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006041933A2 (en) * | 2004-10-05 | 2006-04-20 | Diversa Corporation | Improved vaccines |
| CN102357148A (en) * | 2011-09-30 | 2012-02-22 | 青岛绿曼生物工程有限公司 | Pure Chinese herbal composition for treating Riemerella anatipestifer disease and preparation method thereof |
| CN105055586A (en) * | 2015-08-11 | 2015-11-18 | 河南科技大学 | Traditional Chinese medicine preparation used for preventing and treating cairna moschata infectious serositis |
| CN107715005A (en) * | 2017-11-10 | 2018-02-23 | 广西吉朋投资有限公司 | Prevent and treat Chinese medicine of duck infectious serositis and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 石玉祥: "《禽病辩证论治》", 30 April 2014, 河北科学技术出版社 * |
| 罗长荣: "《畜禽主要疾病防治技术》", 31 August 2015, 四川科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772781B (en) | Traditional Chinese medicine preparation for treating chronic colitis and preparation method thereof | |
| CN103202974A (en) | Traditional Chinese medicine composition for treating coccidiosis in chicken | |
| CN102784337B (en) | Traditional Chinese medicine compound lotion for treating exudative infantile eczema and preparation method thereof | |
| CN101972392A (en) | Chinese medicinal composition for treating chicken colibacillosis and preparation method thereof | |
| CN104887890A (en) | Medicine composition for treating white scour of chicken and preparation method thereof | |
| CN102847021B (en) | Enema for treating ulcerative colitis and preparation method thereof | |
| CN104366123A (en) | Functional feed for preventing infectious pancreatic diseases in rainbow trouts and production method thereof | |
| CN104474104B (en) | A kind of Chinese medicine composition for preventing and treating infectious coryza of chicken and preparation method thereof | |
| CN106173450A (en) | Improve compound feed additive and the feedstuff of pigeon immunity | |
| CN105056159A (en) | Medicine for treating parasitic diseases of pigs and preparation method thereof | |
| CN102488847A (en) | Traditional Chinese medicine composition for treating chicken infectious bursal disease as well as preparation method and application thereof | |
| CN101194995B (en) | Proprietary Chinese medicine for treating animal virus, bacterium and mix infection | |
| CN105560444B (en) | Tibetan medicine composition for treating yak gastroenteritis and preparation method and application thereof | |
| CN108434262A (en) | A kind of Chinese medicine composition of prevention and treatment Riemerella anatipestifer disease | |
| CN108524594A (en) | Invigorating the spleen herbal medicine tea composition, invigorating the spleen herbal medicine tea formulation and preparation method thereof | |
| CN107397886A (en) | Chinese medicine composition for preventing and treating piglet red dysentery and its preparation method and application | |
| CN109432287B (en) | Traditional Chinese medicine oral liquid for preventing and treating excessive heat syndrome of poultry qi system and preparation method thereof | |
| CN106389962A (en) | Traditional Chinese medicinal composition for preventing and treating lamb colibacillosis, and preparation method and application thereof | |
| CN102688430A (en) | Traditional Chinese medicine composition for treating pig eczema, feed, as well as preparation method and application of traditional Chinese composition | |
| CN102861273B (en) | Preparation method of traditional Chinese medicine wet wipes for treating exudative children eczema | |
| CN103690771B (en) | Be used for the treatment of medicine of lamb colibacillosis and preparation method thereof | |
| CN105079602B (en) | Treat the Chinese medicine composition and preparation method thereof of mink diarrhoeal diseases | |
| CN115607614B (en) | Traditional Chinese medicine composition for treating colibacillosis of livestock and poultry and preparation method thereof | |
| CN108497296A (en) | With strengthening the spleen and stomach, the meal replacement powder and preparation method thereof of heart clearing, lung moistening effect | |
| CN107158321A (en) | A kind of Chinese medicine composition for treating post-herpetic neuralgia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180824 |